The Trustees of Columbia University in the City of New York
发明人:
申请号:
EP17736345.4
公开号:
EP3400003A4
申请日:
2017.01.05
申请国别(地区):
EP
年份:
2019
代理人:
摘要:
The present disclosure provides, in one embodiment, a method of treating or preventing an ID2 protein-related disease in a patient at risk of developing or having such a disease by administering to the patient a composition in an amount and for a time sufficient to increase degradation of HIFα in a cell affected by the ID2 protein-related disease in the patent and/or to decrease half-life of HIFα in the cell affected by the ID2 protein-related disease in the patient, as compared to an untreated cell affected by the ID2 protein-related disease.